Characterization of contrast enhancement in the ablation zone immediately after radiofrequency ablation of renal tumors

Journal of Vascular and Interventional Radiology

Volumn 21, Issue 5, 2010, Pages 690-695

  Javadi, Sanaz ^a   Ahrar, Judy U ^a   Ninan, Elizabeth ^a   Gupta, Sanjay ^a   Matin, Surena F ^a   Ahrar, Kamran ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; IODIXANOL; IOVERSOL;

ABLATION ZONE; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; KIDNEY PARENCHYMA; KIDNEY TUMOR; MALE; ONCOLOGICAL PARAMETERS; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RADIOLOGICAL PARAMETERS; RETROSPECTIVE STUDY; TUMOR ABLATION; CATHETER ABLATION; CLINICAL TRIAL; INTERVENTIONAL RADIOLOGY; METHODOLOGY; MIDDLE AGED; PROGNOSIS; RADIOGRAPHY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CATHETER ABLATION; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RADIOGRAPHY, INTERVENTIONAL; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 77956640936     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2009.12.400     Document Type: Article

References (15)

1. Chow WH, Devesa SS, Warren JL, Fraumeni JF Jr. Rising incidence of renal cell cancer in the United States. JAMA 1999; 281:1628 -1631.
2. Levine E, Huntrakoon M, Wetzel LH. Small renal neoplasms: clinical, pathologic, and imaging features. AJR Am J Roentgenol 1989; 153:69 -73.
3. Bosniak MA, Birnbaum BA, Krinsky GA, Waisman J. Small renal parenchymal neoplasms: further observations on growth. Radiology 1995; 197:589-597.
4. Fergany AF, Hafez KS, Novick AC. Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. J Urol 2000; 163:442- 445.
5. Uzzo RG, Novick AC. Nephron sparing surgery for renal tumors: indications, techniques and outcomes. J Urol 2001; 166:6 -18.
6. Breen DJ, Rutherford EE, Stedman B, et al. Management of renal tumors by image-guided radiofrequency ablation: experience in 105 tumors. Cardiovasc Intervent Radiol 2007; 30:936 -942.
7. Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma: part 1, indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol 2005; 185:64 -71.
8. Zagoria RJ, Hawkins AD, Clark PE, et al. Percutaneous CT-guided radiofrequency ablation of renal neoplasms: factors influencing success. AJR Am J Roentgenol 2004; 183:201-207.
9. Farrell MA, Charboneau WJ, DiMarco DS, et al. Imaging-guided radiofrequency ablation of solid renal tumors. AJR Am J Roentgenol 2003; 180:1509-1513.
10. Gervais DA, McGovern FJ, Wood BJ, Goldberg SN, McDougal WS, Mueller PR. Radio-frequency ablation of renal cell carcinoma: early clinical experience. Radiology 2000; 217:665- 672.
11. Javadi S, Matin SF, Tamboli P, Ahrar K. Unexpected atypical findings on CT after radiofrequency ablation for small renal-cell carcinoma and the role of percutaneous biopsy. J Vasc Interv Radiol 2007; 18:1186 -1191.
12. Hegarty NJ, Gill IS, DesaiMM,Remer EM, O'Malley CM, Kaouk JH. Probeablative nephron-sparing surgery: cryoablation versus radiofrequency ablation. Urology 2006; 68:7-13.
13. Weight CJ, Kaouk JH, Hegarty NJ, et al. Correlation of radiographic imaging and histopathology following cryoablation and radio frequency ablation for renal tumors. J Urol 2008; 179: 1277-1281.
14. Matin SF, Ahrar K, Cadeddu JA, et al. Residual and recurrent disease following renal energy ablative therapy: a multi-institutional study. J Urol 2006; 176:1973-1977.
15. Rutherford EE, Cast JE, Breen DJ. Immediate and long-term CT appearances following radiofrequency ablation of renal tumours. Clin Radiol 2008; 63:220 -230.